Evidence map›Paper›PMID 33151031›Full record

ArticleHuman brain mapping2021

Emotion processing and regulation in major depressive disorder: A 7T resting-state fMRI study.

Amir Ebneabbasi, Mostafa Mahdipour, Vahid Nejati, Meng Li, Thomas Liebe, Lejla Colic, Anna Linda Leutritz, Matthias Vogel, Mojtaba Zarei, Martin Walter and 1 more

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 6 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 6 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Semantic fMRI neurofeedback of emotions: from basic principles to clinical applications.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  14. Leveraging ultra-high field (7T) MRI in psychiatric research.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Amir EbneabbasiInstitute of Medical Science and Technology, Shahid Beheshti University, Tehran, Iran.ORCID 0000-0001-9348-5702
Mostafa MahdipourInstitute of Medical Science and Technology, Shahid Beheshti University, Tehran, Iran.
Vahid NejatiDepartment of Psychology, Faculty of Psychology and Educational Sciences, Shahid Beheshti University, Tehran, Iran.
Meng LiClinical Affective Neuroimaging Laboratory, Otto von Guericke University, Magdeburg, Germany.
Thomas LiebeClinical Affective Neuroimaging Laboratory, Otto von Guericke University, Magdeburg, Germany.
Lejla ColicClinical Affective Neuroimaging Laboratory, Otto von Guericke University, Magdeburg, Germany.
Anna Linda LeutritzClinical Affective Neuroimaging Laboratory, Otto von Guericke University, Magdeburg, Germany.ORCID 0000-0002-9650-8970
Matthias VogelClinical Affective Neuroimaging Laboratory, Otto von Guericke University, Magdeburg, Germany.
Mojtaba ZareiInstitute of Medical Science and Technology, Shahid Beheshti University, Tehran, Iran.ORCID 0000-0002-1967-3139
Martin WalterClinical Affective Neuroimaging Laboratory, Otto von Guericke University, Magdeburg, Germany.ORCID 0000-0001-7857-4483
Masoud TahmasianInstitute of Medical Science and Technology, Shahid Beheshti University, Tehran, Iran.ORCID 0000-0003-3999-3807
Shahid Beheshti University · IRJena University Hospital · DEOtto-von-Guericke-Universität Magdeburg · DEUniversity Hospital Magdeburg · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysfunctions in bottom-up emotion processing (EP), as well as top-down emotion regulation (ER) are prominent features in pathophysiology of major depressive disorder (MDD). Nonetheless, it is not clear whether EP- and ER-related areas are regionally and/or connectively disturbed in MDD. In addition, it is yet to be known how EP- and ER-related areas are interactively linked to regulatory behavior, and whether this interaction is disrupted in MDD. In our study, regional amplitude of low frequency fluctuations (ALFF) and whole-brain functional connectivity (FC) of meta-analytic-driven EP- and ER-related areas were compared between 32 healthy controls (HC) and 20 MDD patients. Then, we aimed to investigate whether the EP-related areas can predict the ER-related areas and regulatory behavior in both groups. Finally, the brain-behavior correlations between the EP- and ER-related areas and depression severity were assessed. We found that: (a) affective areas are regionally and/or connectively disturbed in MDD; (b) EP-ER interaction seems to be disrupted in MDD; overburden of emotional reactivity in amygdala may inversely affect cognitive control processes in prefrontal cortices, which leads to diminished regulatory actions. (c) Depression severity is correlated with FC of affective areas. Our findings shed new lights on the neural underpinning of affective dysfunctions in depression.

Indexed as

AdultAffective SymptomsAmygdalaCerebral CortexConnectomeEmotional RegulationFemaleHumansMagnetic Resonance ImagingMajor Depressive DisorderMaleMiddle AgedSeverity of Illness Indexamplitude of low frequency fluctuationsemotion processingemotion regulationfunctional connectivitymajor depressive disorder

Identifiers

PMID33151031
PMCPMC7814754
OpenAlexW3095366800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.